axillary dissection vs radiation for residual nodal disease after neoadjuvant systemic therapy
Published 1 year ago • 782 plays • Length 1:49Download video MP4
Download video MP3
Similar videos
-
1:09
the role of axillary dissection to determine nodal burden to inform systemic therapy recommendations
-
5:02
omitting axillary lymph node dissection in breast cancer patients after neoadjuvant chemotherapy
-
1:13
taxis: axillary dissection to determine nodal burden to inform systemic therapy in node-positive bc
-
0:57
role of axillary dissection in breast cancer
-
19:51
targeted axillary dissection to minimize axillary surgery post neoadjuvant systemic therapy
-
3:46
evidence-based approach to lymph node assessment and targeted axillary dissection
-
10:28
axillary management of node-positive breast cancer after neoadjuvant chemotherapy
-
4:53
difference between sentinel biopsy and axillary dissection following neoadjuvant therapy
-
0:55
can we forego axillary lymph node dissection in early breast cancer?
-
0:52
de-escalation of axillary radiotherapy in early breast cancer
-
3:10
practical approach to the management of the axilla after neoadjuvant chemotherapy
-
1:42
nodal recurrence following axillary downstaging with neoadjuvant chemotherpay omission of alnd
-
1:16
state of the art of surgery in patients with early breast cancer
-
2:21
radiation to lymph nodes versus axillary dissection after positive slnb amaros study breast cancer
-
15:50
axillary radiotherapy & lymph node surgery: comparable 10-year outcomes for breast cancer
-
2:20
axillary surgery de-escalation in node-positive breast cancer
-
5:31
management of axilla after neo-adjuvant treatment
-
1:34
axillary surgery trends in breast cancer after neoadjuvant treatment
-
9:55
radiation-free targeted axillary dissection